Iterum Therapeutics plc (ITRM) Net Income by Year
Iterum Therapeutics plc reported a net loss of $24.8M in fiscal year 2024. This represents an increase of 35.4% from the prior fiscal year. The table below carries 9 fiscal years, from 2016 to 2024, and the quarters Iterum Therapeutics plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ITRM Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2410-Q | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$24.8M+35.4% | -$38.4M+13.6% | -$44.4M+51.5% | -$91.6M-76.1% | -$52.0M+49.6% | -$103.1M-33.8% | -$77.1M-162.0% | -$29.4M-118.4% | -$13.5M |
ITRM Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Iterum Therapeutics plc financials
Frequently Asked Questions
What was Iterum Therapeutics plc's net income in fiscal year 2024?
Iterum Therapeutics plc reported a net loss of $24.8M in fiscal year 2024.
How fast is Iterum Therapeutics plc's net income growing?
Iterum Therapeutics plc (ITRM) net income rose by 35.4% year over year, from -$38.4M to -$24.8M in fiscal year 2024.
How has Iterum Therapeutics plc's net income changed over the years?
Across the 9 fiscal years this page covers, Iterum Therapeutics plc (ITRM) net income went from -$13.5M in fiscal year 2016 to -$24.8M in fiscal year 2024.
What was Iterum Therapeutics plc's net income in the most recent quarter?
Iterum Therapeutics plc (ITRM) reported -$9.0M in net income in Q3 2025. This represents a decrease of 47.3% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Iterum Therapeutics plc (ITRM) reported on that line in every period on record.